Cytomed Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.93

-0.03 (-3.14%)

As of Sep 28, 10:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,528.1% upside

Low Target $15.00

Average Target $24.31

High Target $29.94

Current Price $0.93

Current
$0.93

Target
$24.31

$15.00 $24.31 avg $29.94

Scenario Analysis

Bear Case

$15.00

1,521.6%

Low target

Base Case

$24.31

+2,528.1%

Avg target

Bull Case

$29.94

+3,136.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.68

-74.9% from high

52-Week Low

$0.68

+36.0% from low

Target vs 52W High

$24.31

+560.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%